Tokyo, Aug. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058748) titled 'A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders' on Aug. 9.
Study Type:
Observational
Primary Sponsor:
Institute - Mukumi Clinic
Condition:
Condition - Lymphedema and Lymphatic Disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To retrospectively analyze treatment outcomes for lymphedema and other lymphatic disorders at our institution, and to evaluate the usefulness and validity of our diagnostic and therapeutic approaches.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who visited the Mukumi Clinic between November 1, 2018, and March 31, 2025, and were diagnosed with lymphedema or other lymphatic disorders.
Key exclusion criteria - 1. Patients deemed unsuitable for inclusion in the study by the principal investigator.
2. Patients who declined to participate in the study.
Target Size - 989
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 07 Month 15 Day
Date of IRB - 2025 Year 07 Month 15 Day
Anticipated trial start date - 2025 Year 07 Month 15 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067173
Disclaimer: Curated by HT Syndication.
